share_log

Lexaria Bioscience Announces That It Has Received Partial 12-Week Body Weight Results From The Recently Completed Animal Study WEIGHT-A24-1

Benzinga ·  Oct 22, 2024 21:28

DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing weight loss groups

Accelerated rates of weight loss were experienced during the final 4 weeks of the study in all DehydraTECH groups

KELOWNA, BC / ACCESSWIRE / October 22, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received partial 12-week (final) body weight results from the recently completed animal study WEIGHT-A24-1 (the "Study").

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment